Literature DB >> 2684011

Aminoglycoside uptake increased by tet gene expression.

T L Merlin1, G E Davis, W L Anderson, R K Moyzis, J K Griffith.   

Abstract

The expression of extrachromosomal tet genes not only confers tetracycline resistance but also increases the susceptibilities of gram-negative bacteria to commonly used aminoglycoside antibiotics. We investigated the possibility that tet expression increases aminoglycoside susceptibility by increasing bacterial uptake of aminoglycoside. Studies of [3H]gentamicin uptake in paired sets of Escherichia coli HB101 and Salmonella typhimurium LT2 expressing and not expressing tet showed that tet expression accelerates energy-dependent [3H]gentamicin uptake. Increased [3H]gentamicin uptake was accompanied by decreased bacterial protein synthesis and bacterial growth. Increased aminoglycoside uptake occurred whether tet expression was constitutive or induced, whether the tet gene was class B or C, and whether the tet gene was plasmid borne or integrated into the bacterial chromosome. tet expression produced no measurable change in membrane potential, suggesting that tet expression increases aminoglycoside uptake either by increasing the availability of specific carriers or by lowering the minimum membrane potential that is necessary for uptake.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684011      PMCID: PMC172700          DOI: 10.1128/AAC.33.9.1549

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Enhanced gentamicin killing of Escherichia coli by tet gene expression.

Authors:  T L Merlin; D L Corvo; J H Gill; J K Griffith
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Revised interpretation of the origin of the pSC101 plasmid.

Authors:  S N Cohen; A C Chang
Journal:  J Bacteriol       Date:  1977-11       Impact factor: 3.490

3.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

4.  Positive selection for loss of tetracycline resistance.

Authors:  B R Bochner; H C Huang; G L Schieven; B N Ames
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

5.  Plasmid-conferred tetracycline resistance confers collateral cadmium sensitivity of E. coli cells.

Authors:  J K Griffith; J M Buckingham; J L Hanners; C E Hildebrand; R A Walters
Journal:  Plasmid       Date:  1982-07       Impact factor: 3.466

6.  Selection for loss of tetracycline resistance by Escherichia coli.

Authors:  S R Maloy; W D Nunn
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

7.  Tetracycline resistance element of pBR322 mediates potassium transport.

Authors:  D C Dosch; F F Salvacion; W Epstein
Journal:  J Bacteriol       Date:  1984-12       Impact factor: 3.490

8.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

9.  Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.

Authors:  L McMurry; R E Petrucci; S B Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Multicopy Tn10 tet plasmids confer sensitivity to induction of tet gene expression.

Authors:  H S Moyed; T T Nguyen; K P Bertrand
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

View more
  10 in total

Review 1.  Multidrug evolutionary strategies to reverse antibiotic resistance.

Authors:  Michael Baym; Laura K Stone; Roy Kishony
Journal:  Science       Date:  2016-01-01       Impact factor: 47.728

2.  Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.

Authors:  G Potel; J Caillon; B Fantin; J Raza; F Le Gallou; J Y Lepage; P Le Conte; D Bugnon; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Potentiation by salicylate and salicyl alcohol of cadmium toxicity and accumulation in Escherichia coli.

Authors:  J L Rosner; M Aumercier
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents.

Authors:  W H Wang; W M Wong; D Dailidiene; D E Berg; Q Gu; K C Lai; S K Lam; B C Y Wong
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

Review 5.  Collateral sensitivity of antibiotic-resistant microbes.

Authors:  Csaba Pál; Balázs Papp; Viktória Lázár
Journal:  Trends Microbiol       Date:  2015-03-25       Impact factor: 17.079

6.  Plasmids shape the diverse accessory resistomes of Escherichia coli ST131.

Authors:  Arun Gonzales Decano; Nghia Tran; Hawriya Al-Foori; Buthaina Al-Awadi; Leigh Campbell; Kevin Ellison; Louisse Paolo Mirabueno; Maddy Nelson; Shane Power; Genevieve Smith; Cian Smyth; Zoe Vance; Caitriona Woods; Alexander Rahm; Tim Downing
Journal:  Access Microbiol       Date:  2020-11-18

7.  MexXY multidrug efflux system of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

8.  Compounds that select against the tetracycline-resistance efflux pump.

Authors:  Laura K Stone; Michael Baym; Tami D Lieberman; Remy Chait; Jon Clardy; Roy Kishony
Journal:  Nat Chem Biol       Date:  2016-09-19       Impact factor: 15.040

9.  An efficient platform for genetic selection and screening of gene switches in Escherichia coli.

Authors:  Norihito Muranaka; Vandana Sharma; Yoko Nomura; Yohei Yokobayashi
Journal:  Nucleic Acids Res       Date:  2009-02-03       Impact factor: 16.971

10.  A high capacity microbial screen for inhibitors of human rhinovirus protease 3C.

Authors:  J O McCall; S Kadam; L Katz
Journal:  Biotechnology (N Y)       Date:  1994-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.